379 related articles for article (PubMed ID: 32777751)
1. The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) and adjuvant chemotherapy.
Ernani V; Appiah AK; Baine MJ; Smith LM; Ganti AK
Cancer Treat Res Commun; 2020; 24():100197. PubMed ID: 32777751
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant Systemic Therapy in Patients With Early-Stage NSCLC Treated With Stereotactic Body Radiation Therapy.
Ernani V; Appiah AK; Marr A; Zhang C; Zhen W; Smith LM; Ganti AK
J Thorac Oncol; 2019 Mar; 14(3):475-481. PubMed ID: 30503890
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis.
Foster CC; Rusthoven CG; Sher DJ; Feldman L; Pasquinelli M; Spiotto MT; Koshy M
Lung Cancer; 2019 Apr; 130():162-168. PubMed ID: 30885339
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy following SBRT for early stage non-small cell lung cancer (NSCLC) in older patients.
Grinnell M; Appiah AK; Baine M; Ernani V; Marr A; Zhang C; Zhen W; Buddharaju LNR; Smith LM; Ganti AK
J Geriatr Oncol; 2020 Sep; 11(7):1145-1153. PubMed ID: 32389520
[TBL] [Abstract][Full Text] [Related]
5. Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer.
Baine MJ; Verma V; Schonewolf CA; Lin C; Simone CB
Lung Cancer; 2018 Apr; 118():20-26. PubMed ID: 29571997
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic Body Radiation Therapy Versus Nonradiotherapeutic Ablative Procedures (Laser/Cryoablation and Electrocautery) for Early-Stage Non-Small Cell Lung Cancer.
Baine MJ; Sleightholm R; Neilsen BK; Oupický D; Smith LM; Verma V; Lin C
J Natl Compr Canc Netw; 2019 May; 17(5):450-458. PubMed ID: 31085762
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.
Iyengar P; Kavanagh BD; Wardak Z; Smith I; Ahn C; Gerber DE; Dowell J; Hughes R; Abdulrahman R; Camidge DR; Gaspar LE; Doebele RC; Bunn PA; Choy H; Timmerman R
J Clin Oncol; 2014 Dec; 32(34):3824-30. PubMed ID: 25349291
[TBL] [Abstract][Full Text] [Related]
8. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
9. A National Cancer Database Analysis of Radiofrequency Ablation versus Stereotactic Body Radiotherapy in Early-Stage Non-Small Cell Lung Cancer.
Lam A; Yoshida EJ; Bui K; Fernando D; Nelson K; Abi-Jaoudeh N
J Vasc Interv Radiol; 2018 Sep; 29(9):1211-1217.e1. PubMed ID: 30061058
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC).
von Reibnitz D; Shaikh F; Wu AJ; Treharne GC; Dick-Godfrey R; Foster A; Woo KM; Shi W; Zhang Z; Din SU; Gelblum DY; Yorke ED; Rosenzweig KE; Rimner A
Acta Oncol; 2018 Nov; 57(11):1567-1573. PubMed ID: 29873277
[TBL] [Abstract][Full Text] [Related]
11. Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: A National Cancer Database study.
Wu J; Bai HX; Chan L; Su C; Zhang PJ; Yang L; Zhang Z
J Thorac Cardiovasc Surg; 2020 Nov; 160(5):1350-1357.e11. PubMed ID: 32033815
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis.
Kann BH; Miccio JA; Stahl JM; Ross R; Verma V; Dosoretz AP; Park HS; Shafman TD; Gross CP; Yu JB; Decker RH
Radiother Oncol; 2019 Mar; 132():188-196. PubMed ID: 30391106
[TBL] [Abstract][Full Text] [Related]
13. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer.
Ager BJ; Wells SM; Gruhl JD; Stoddard GJ; Tao R; Kokeny KE; Hitchcock YJ
Lung Cancer; 2019 Dec; 138():6-12. PubMed ID: 31593894
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma.
Abel S; Hasan S; White R; Schumacher L; Finley G; Colonias A; Wegner RE
Lung Cancer; 2019 Feb; 128():127-133. PubMed ID: 30642444
[TBL] [Abstract][Full Text] [Related]
16. Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness.
Jacobs CD; Gao J; Wang X; Clarke JM; Tong B; Ready NE; Suneja G; Kelsey CR; Torok JA
Clin Lung Cancer; 2020 May; 21(3):238-246. PubMed ID: 31757764
[TBL] [Abstract][Full Text] [Related]
17. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer.
Robinson CG; DeWees TA; El Naqa IM; Creach KM; Olsen JR; Crabtree TD; Meyers BF; Puri V; Bell JM; Parikh PJ; Bradley JD
J Thorac Oncol; 2013 Feb; 8(2):192-201. PubMed ID: 23287852
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer.
Haque W; Verma V; Polamraju P; Farach A; Butler EB; Teh BS
Radiother Oncol; 2018 Nov; 129(2):264-269. PubMed ID: 30031630
[TBL] [Abstract][Full Text] [Related]
19. Comparing Outcomes of Patients With Early-Stage Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Frailty Status.
Raghavan G; Shaverdian N; Chan S; Chu FI; Lee P
Clin Lung Cancer; 2018 Sep; 19(5):e759-e766. PubMed ID: 29954680
[TBL] [Abstract][Full Text] [Related]
20. Higher biologically effective dose is associated with improved survival in patients with squamous cell carcinoma of the lung treated with stereotactic body radiation therapy.
Parzen JS; Almahariq MF; Quinn TJ; Siddiqui ZA; Thompson AB; Guerrero T; Lee K; Stevens C; Grills IS
Radiother Oncol; 2021 Jul; 160():25-31. PubMed ID: 33892021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
